Colinz Laboratories Limited (BSE: 531210)
Health Care · Pharmaceuticals · IN
Rs73.03
-0.64% today · +70.4% 1Y
Colinz Laboratories Limited (BSE: 531210) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.90M.
Over the last twelve months the share price has gained 70.4%, trading between 36.11 and 87.91.
Tweenvest scores Colinz Laboratories Limited across four factors: quality 79/100, value 46/100, growth 14/100. Its strongest factor is quality.
531210 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.90M
- Revenue (TTM)
- $614.57K
- P/E
- 6.58
- EPS
- 11.11
- Dividend yield
- —
- Beta (5Y)
- -0.09
- 52-week high
- Rs87.91
- 52-week low
- Rs36.11
- Avg volume (3M)
- —
- Shares outstanding
- 2.52M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hamps Bio LimitedBSE: 544312 | $2.30M | Rs25.50 | +0.24% |
| BioVaxys Technology Corp.CNSX: BIOV | $2.27M | CA$— | — |
| Cannabis Strategic VenturesOTCPK: NUGS | $1.97M | $0.00 | -30.99% |
| City View Green Holdings Inc.CNSX: CVGR | $1.90M | CA$0.04 | -12.50% |
| Kanabo Group PlcLSE: KNB | $1.86M | £— | — |
| Delivra Health Brands Inc.TSXV: DHB | $1.86M | CA$0.09 | +6.25% |
| Artelo Biosciences, Inc.NasdaqCM: ARTL | $1.79M | $3.17 | -2.76% |
| Venmax Drugs and Pharmaceuticals LimitedBSE: 531015 | $1.72M | Rs14.40 | -0.69% |
Figures last refreshed Oct 11, 2026.